| 0.0901 -0.001 (-1.23%) | 04-26 10:31 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 0.13 | 1-year : | 0.15 |
| Resists | First : | 0.11 | Second : | 0.13 |
| Pivot price | 0.09 |
|||
| Supports | First : | 0.07 | Second : | 0.06 |
| MAs | MA(5) : | 0.09 |
MA(20) : | 0.09 |
| MA(100) : | 0.14 |
MA(250) : | 0.58 |
|
| MACD | MACD : | -0.1  |
Signal : | -0.1 |
| %K %D | K(14,3) : | 19.6 |
D(3) : | 21 |
| RSI | RSI(14): 42.2 |
|||
| 52-week | High : | 1.78 | Low : | 0.04 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ SONX ] has closed above bottom band by 38.4%. Bollinger Bands are 74.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 19 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.09 - 0.09 | 0.09 - 0.09 |
| Low: | 0.09 - 0.09 | 0.09 - 0.09 |
| Close: | 0.09 - 0.09 | 0.09 - 0.09 |
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment device for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. Sonendo, Inc. was incorporated in 2006 and is headquartered in Laguna Hills, California.
Wed, 24 Apr 2024
Sonendo, Inc. to Report First Quarter 2024 Financial Results on May 8, 2024 - Business Wire
Mon, 18 Mar 2024
Sonendo director buys $80k in common stock By Investing.com - Investing.com
Tue, 12 Mar 2024
Sonendo shares downgraded to hold, price target slashed to $0.25 - Investing.com
Tue, 12 Mar 2024
Sonendo Inc. on the Brink: NYSE Suspension and Delisting Risks Shake Investor Confidence - TipRanks.com - TipRanks
Mon, 11 Mar 2024
Sonendo, Inc. (SONX) Q4 2023 Earnings Call Transcript - Seeking Alpha
Fri, 08 Mar 2024
Sonendo Announces CFO Resignation and Interim Successor - TipRanks.com - TipRanks
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 67 (M) |
| Shares Float | 50 (M) |
| Held by Insiders | 13.9 (%) |
| Held by Institutions | 29 (%) |
| Shares Short | 411 (K) |
| Shares Short P.Month | 265 (K) |
| EPS | -0.65 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.44 |
| Profit Margin | -138.9 % |
| Operating Margin | -82.2 % |
| Return on Assets (ttm) | -31.4 % |
| Return on Equity (ttm) | -110.4 % |
| Qtrly Rev. Growth | -4.5 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0.65 |
| EBITDA (p.s.) | -0.79 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -46 (M) |
| Levered Free Cash Flow | -21 (M) |
| PE Ratio | -0.14 |
| PEG Ratio | 0 |
| Price to Book value | 0.2 |
| Price to Sales | 0.13 |
| Price to Cash Flow | -0.14 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|